Elucidating Biosimilars Characterization
September 30, 2013 - Adeline Siew, PhD. BioPharm International Magazine
…
A Platform Approach for the Purification of Domain Antibodies (Da
September 30, 2013 - Cytiva
…
The use of Xcellerexâ„¢ mixing system as slurry tank when packing
September 23, 2013 - Cytiva
…
Prescribing Caution for Biosimilars
September 20, 2013 - James C. Greenwood, Biopharm International Magazine
In statehouses around the country, lawmakers are beginning to
HT Multi-Product Liquid Chromatography for Characterization of Mo
September 16, 2013 - Jennifer C. Rea, PhD, G. Tony Moreno, Yun Lou, Rahul Parikh, Dell Farnan, PhD , Biopharm Internation
If used correctly, these new analytical methods can reduce analysis and product development time.
…
The Development and Application of a Monoclonal Antibody Purifica
September 16, 2013 - By: Judy Glynn, Timothy Hagerty, Timothy Pabst, PhD, Gopinath Annathur, Kristin Thomas, Paul Johnson
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase the
…
Stirring up the fermentation game
September 8, 2013 - Cytiva
Microbial fermentation in single-use Xcellerexâ„¢ XDR-50 MO fermentor system
Regulatory Challenges in the QbD Paradigm
September 3, 2013 - Anastasia G. Lolas, Anurag S. Rathore. Biopharm International Magazine
The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical tren
…
Report from India
September 3, 2013 - Jane Wan, Biopharm International Magazine
Essentials in Quality Risk Management
August 23, 2013 - Thomas A. Little, PhD, Biopharm International Magazine
Quality risk management is an essential element of every aspect of drug development and manufacturing throughout the product lifecycle.